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Résumé en
anglais
HPV prophylactic vaccination based on VLPs was implemented 7 years ago and has
now shown a high degree of efficiency to reduce HPV-induced lesions. Moreover, it
was shown that HPV-derived virus-like particles or pseudovirions could be used as
gene therapy vectors. As a consequence, characterization of the antigenic structure
of HPV capsids is crucial for designing future HPV vaccines with better or broader
efficacy and for the design of HPV-derived gene therapy vectors with reduced
immunogenicity or vaccination escaping. In this study, we have generated 10
HPV16 FG loop L1 protein mutants and analyzed their ability to self-assemble into
VLP, their immunogenicity, and their ability to transduce cells when used as
pseudovirions. Most of the mutants had lost their ability to transduce cells at the
exception of two chimeric HPV16/31 L1 protein FG loop mutants. Sera from mice
immunized with HPV16 L1 wt VLPs very weakly neutralized pseudovirions derived
from these two HPV16/31 L1 protein FG loop mutants. These findings suggest that
only a few point substitutions within the FG loop are sufficient to generate a new
serotype escaping vaccination. As a consequence, derived pseudovirions might be
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